Does VANDETANIB Cause Neoplasm malignant? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Neoplasm malignant have been filed in association with VANDETANIB (CAPRELSA). This represents 0.6% of all adverse event reports for VANDETANIB.
7
Reports of Neoplasm malignant with VANDETANIB
0.6%
of all VANDETANIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From VANDETANIB?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VANDETANIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does VANDETANIB Cause?
Diarrhoea (216)
Fatigue (109)
Rash (101)
Electrocardiogram qt prolonged (89)
Hypertension (88)
Disease progression (62)
Acne (60)
Nausea (58)
Asthenia (52)
Headache (48)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which VANDETANIB Alternatives Have Lower Neoplasm malignant Risk?
VANDETANIB vs VARDENAFIL
VANDETANIB vs VARENICLINE
VANDETANIB vs VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
VANDETANIB vs VASOPRESSIN
VANDETANIB vs VECTIBIX